UMIN ID: UMIN000018263
Registered date:09/07/2015
Which Japanese patients with type 1 diabetes would benefit from continuous subcutaneous insulin infusion?
Basic Information
Recruitment status | Complete: follow-up complete |
---|---|
Health condition(s) or Problem(s) studied | Endocrinology and Metabolism |
Date of first enrollment | 2005/03/01 |
Target sample size | 28 |
Countries of recruitment | Japan |
Study type | Observational |
Intervention(s) |
Outcome(s)
Primary Outcome | HbA1c |
---|---|
Secondary Outcome |
Key inclusion & exclusion criteria
Age minimum | 20years-old |
---|---|
Age maximum | 80years-old |
Gender | Male and Female |
Include criteria | |
Exclude criteria | severe visual impairment, hearing disturbance, and those who could not perform self-monitoring of blood glucose at least four times per day. |
Related Information
Primary Sponsor | The jikei university school of medicine |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | The Jikei University School of Medicine, Division of Diabetes, Metabolism and Endocrinology, Department of Internal Medicine |
Secondary ID(s) |
Contact
public contact | |
Name | Kentaro Taki |
Address | 3-25-8,nishishinbashi,minato-ku,tokyo Japan |
Telephone | 03-3433-1111 |
tackey@jikei.ac.jp | |
Affiliation | The Jikei university school of medicine Diabetes,metabolism and endocrinology |
scientific contact | |
Name | Kentaro Taki |
Address | 3-25-8,nishi-shinbashi,minato-ku,Tokyo,japan Japan |
Telephone | 03-3433-1111 |
tackey@jikei.ac.jp | |
Affiliation | The Jikei university school of medicine Diabetes,metabolism and endocrinology |